Physician profile
Amit Jain
NPI 1497080873
$1,321.90
in general payments reported to CMS, 2019-2025
13 companies · $121 in 2025
The $121 reported for 2025 was less than what a typical Pediatric Pulmonology provider received nationally (typical 2025 total: $140).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $73.76 · 2022: $129 · 2023: $136 · 2024: $862 · 2025: $121.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $674 · Food and Beverage: $427 · Education: $17.38.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $674.26 |
| Food and Beverage | $427.18 |
| Education | $17.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Products, INC. | $783.78 | 2023-2024 | |
| Sanofi Pasteur INC. | $115.98 | 2022 | |
| Ethicon INC. | $95.92 | 2024 | Spine & Trauma 3d Navigation |
| Genentech USA, INC. | $73.76 | 2019 | |
| Viatris Specialty LLC | $53.16 | 2025 | Tobi Podhaler |
| Astrazeneca Pharmaceuticals LP | $44.58 | 2022-2025 | Fasenra |
| Digestive Care, INC. | $37.65 | 2024 | Pertzye |
| Insmed, INC. | $32.61 | 2025 | Brinsupri |
| Genzyme Corporation | $26.88 | 2023 | |
| Baxter Healthcare | $21.12 | 2024 | Hillrom - Vest System Model 105 Home Care |
| Philips North America LLC | $18.63 | 2024 | (Ak6) Vest Therapy |
| Aimmune Therapeutics, INC. | $17.83 | 2025 | Zenpep |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amit Jain listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.